C12N 2740/13045
Special targeting system for viral vectors
C12N2740/13045 (Special targeting system for viral vectors) appears on 118 US grants and 134 published applications in this corpus.
Search patents in C12N- Granted patents
- 118
- Published applications
- 134
- Assignees
- 87
- Inventors
- 245
- Latest grant
- 10 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 3 |
| 2002 | 11 | 13 |
| 2003 | 6 | 11 |
| 2004 | 7 | 6 |
| 2005 | 4 | 8 |
| 2006 | 6 | 13 |
| 2007 | 3 | 4 |
| 2008 | 6 | 15 |
| 2009 | 3 | 8 |
| 2010 | 8 | 6 |
| 2011 | 2 | 4 |
| 2012 | 7 | 7 |
| 2013 | 4 | 2 |
| 2014 | 10 | 3 |
| 2015 | 3 | 3 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 2 |
| 2019 | 1 | 2 |
| 2020 | 2 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 2 |
| 2023 | 2 | 0 |
| 2024 | 1 | 4 |
| 2025 | 0 | 9 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ex vivo antibody production10 Sep 2024US 12,084,681 B2Kling Biotherapeutics B.V.
- Retroviral and lentiviral vectors14 Nov 2023US 11,814,641 B2Autolus Limited
- Retroviral and lentiviral vectors28 Feb 2023US 11,591,613 B2Autolus Limited
- Retroviral and lentiviral vectors23 Mar 2021US 10,954,530 B2Autolus Limited
- Packaging cell for making a pseudotyped lentivirus30 Jun 2020US 10,696,984 B2California Institute of Technology
- Pseudotyped viral particles for targeting tcr-expressing cells6 Aug 2026US 2026/0226500 A1Regeneron Pharmaceuticals, Inc.
- Cell therapy28 May 2026US 2026/0144873 A1The Walter and Eliza Hall Institute of Medical Research
- Methods and compositions for the treatment of cancer by targeting oncogenic transfer rnas21 May 2026US 2026/0139250 A1Children's Medical Center Corporation
- Glycoproteins for pseudotyping retroviral vector particles25 Dec 2025US 2025/0388924 A1Medizinische Hochschule Hannover
- Retroviral and Lentiviral Vectors25 Dec 2025US 2025/0388929 A1Autolus Limited
Most cited
By later US patents
- Recombinant retroviruses with amphotropic and ecotropic host ranges83US 5,449,614 AWhitehead Institue For Biomedical Research · 1995
- Recombinant viruses displaying a nonviral polypeptide on their external surface52US 5,723,287 AMedical Research Council · 1998
- Methods and means for targeted gene delivery51US 7,033,834 B2Crucell Holland B. V. · 2006
- Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery44US 6,416,997 B1The Trustees of the University of Pennsylvania · 2002
- Gene delivery system and methods of use37US 6,899,871 B2University of Southern California · 2005